P1319 ONCE-DAILY SIMEPREVIR (TMC435) WITH PEGINTERFERON/RIBAVIRIN IN TREATMENT-NAIVE OR TREATMENT-EXPERIENCED CHRONIC HCV GENOTYPE 4-INFECTED PATIENTS: FINAL RESULTS OF A PHASE III TRIAL

Authors :: Christophe Hézode
Fabien Zoulim
Sven Francque
Oliver Lenz
Monika Peeters
Patrick Marcellin
Sivi Ouwerkerk-Mahadevan
Suzanne Bourgeois
W. Jessner
Christophe Moreno
Didier Samuel
M. Beumont-Mauviel
Jean-Didier Grangé
Source :: Journal of Hepatology. 60:S535
Publication Year :: 2014
Publisher :: Elsevier BV, 2014.

Subjects :: Therapy naive
Simeprevir
medicine.medical_specialty
Hepatology
business.industry
Internal medicine
Genotype
Medicine
Once daily
business
PEGINTERFERON/RIBAVIRIN
Gastroenterology
Treatment experienced

Tools